8.10
-0.0374(-0.46%)
Currency In USD
Previous Close | 8.13 |
Open | 8.25 |
Day High | 8.25 |
Day Low | 8.09 |
52-Week High | 10 |
52-Week Low | 6.55 |
Volume | 2,767 |
Average Volume | 6,177 |
Market Cap | 39.16M |
PE | -89.96 |
EPS | -0.09 |
Moving Average 50 Days | 7.76 |
Moving Average 200 Days | 8.32 |
Change | -0.04 |
If you invested $1000 in Daxor Corporation (DXR) 10 years ago, it would be worth $1,158.6 as of June 01, 2025 at a share price of $8.097. Whereas If you bought $1000 worth of Daxor Corporation (DXR) shares 5 years ago, it would be worth $599.74 as of June 01, 2025 at a share price of $8.097.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Daxor Announces Duke University Study on Blood Volume Analysis in Heart Failure Published in American Heart Journal
GlobeNewswire Inc.
May 14, 2025 12:00 PM GMT
Published Research Demonstrates the Value of BVA in Meeting Key Goal of Identifying Anemia in Heart Failure Patients Oak Ridge, TN, May 14, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in blood volu
Daxor's Blood Volume Analysis Diagnostic Reaches Two New U.S. Healthcare Systems
GlobeNewswire Inc.
May 13, 2025 12:00 PM GMT
Gold-Standard Technology Now Available in East Tennessee and Pacific Northwest Through Strategic Dual-Model Implementation Oak Ridge, TN, May 13, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), Daxor Corporation, the global leader in bloo
Florida Healthcare Leader Embraces Daxor Blood Volume Analysis Technology
GlobeNewswire Inc.
May 07, 2025 12:00 PM GMT
Daxor's ezBVA Lab Service Marks New Standard in Precision Fluid Management Oak Ridge, TN, May 07, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the opening of a n